Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Efficacy of Olesoxime (TRO19622) in 3-25 Years SMA Patients.
This study is ongoing, but not recruiting participants.
Study NCT01302600   Information provided by Trophos

First Received on February 18, 2011.   Last Updated on December 27, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Spinal Muscular Atrophy Type II
Additional conditions recognized in this trial
Atrophy
Muscular Atrophy
Muscular Atrophy, Spinal
Spinal Muscular Atrophies of Childhood
More general conditions related to this trial
Central Nervous System Diseases
Genetic Diseases, Inborn
Heredodegenerative Disorders, Nervous System
Motor Neuron Disease
Nervous System Diseases
Neurodegenerative Diseases
Neurologic Manifestations
Neuromuscular Diseases
Neuromuscular Manifestations
Pathological Conditions, Anatomical
Signs and Symptoms
Spinal Cord Diseases
Interventions listed in this trial
Olesoxime
Placebo
Sponsors listed in this trial
Trophos
Association Française contre les Myopathies (AFM), Paris


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services